Current stock page

Catalysts

STOK Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

STOKStoke Therapeutics, Inc.

Healthcare / Biotechnology

Low Priority

Relative Laggard

BearishEdge 2/10
$26.68+$0.48 (+1.83%)

Latest quote

  • Momentum
    47
  • Value
    22
  • Quality
    42
  • Risk resilience
    59
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Mar 15, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 42/100

Momentum 47/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment 31.34%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 47/100AIQ Edge 2/10 Relative Laggard
Beat rate
50%
4 of 8 reported periods
Average surprise
+78.3%
Across covered historical reports
Latest result
-16.2%
Oct 29, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 29, 2026—-$0.93-$1.08-16.2%$8.21M$11.26M
Aug 3, 2026—-$0.80-$0.93-17.0%$4.89M$9.33M
May 7, 2026—-$0.80-$0.79+1.3%$6.48M$6.23M
Mar 16, 2026—-$0.75-$0.97-29.3%$5.83M$1.4M
Nov 4, 2025—-$0.54-$0.65-20.4%$4.56M$10.63M
Aug 12, 2025—-$0.57-$0.40+29.8%$5.36M$13.82M
May 13, 2025—-$0.37$1.90+613.5%$31.51M$158.57M
Mar 18, 2025—-$0.51-$0.18+64.7%$3.86M$22.61M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
14
Buy
12-month analyst target
$43.00
+61.17% versus current price
Based on 14 analyst observations. Targets are estimates, not predictions.
Low target
$43.00
+61.17% vs latest price
Average target
$43.00
+61.17% vs latest price
High target
$43.00
+61.17% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateMar 15, 2027

Next known earnings or reporting date.

EPS estimate-$1.15

Current analyst expectation for the upcoming report.

Revenue estimate$8.04M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score47

Where event reaction would show up first.

AIQ score42/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
14
Average target
$43.00
Target upside
61.17%
Target range
$43.00 - $43.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
0
seekingalpha.com · Nov 3, 2026

Stoke Therapeutics, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:STOK) 2026-11-03

2026-11-03. The following slide deck was published by Stoke Therapeutics, Inc.

zacks.com · Oct 29, 2026

Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of -22.73% and +35.88%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

seekingalpha.com · Oct 19, 2026

Stoke Therapeutics: The Market Misread A Key FDA Win (NASDAQ:STOK)

Explore Stoke Therapeutics (STOK) ahead of the 2027 zorevunersen Dravet readout—cash runway to 2028, FDA endpoint edge, and upside valuation.

gurufocus.com · Sep 23, 2026

STOK Looks 163.2% Overvalued on GF Value™

On September 23, 2026, Stoke Therapeutics Inc (NASDAQ: STOK) announced a significant change in its Board of Directors with the appointment of Bo Cumbo, coincidi

Open full news and sentiment

STOK Catalysts FAQ

What are the next catalysts for STOK stock?

STOK's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move STOK stock?

Upcoming events that could move STOK include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could STOK's next earnings report affect the stock?

STOK's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive STOK stock higher?

STOK could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt STOK stock?

STOK could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.